1-6 of 6
Jane N. Winter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy

Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason Romancik, Pamela Allen, Tamara K. Moyo, Vaishalee Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin David, Megan M. Herr, Oluwatobi Odetola, Adam Lin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Ishan Roy, Deborah Stephens, Alexey Danilov, Nirav N. Shah, Stefan K. Barta, Matthew Cortese, Jonathon B. Cohen, Leo I. Gordon, Reem Karmali
Journal: Blood Advances
Blood Adv (2024) 8 (10): 2327–2331.
https://doi.org/10.1182/bloodadvances.2024012573
Published: 2024
Journal Articles

Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma

Clinical Trials & Observations
Reem Karmali, Jeremy S. Abramson, Deborah M. Stephens, Jeffrey Barnes, Jane N. Winter, Shuo Ma, Juehua Gao, Jason Kaplan, Adam M. Petrich, Ephraim Hochberg, Tak Takvorian, Xinlei Mi, Valerie Nelson, Leo I. Gordon, Barbara Pro
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7361–7368.
https://doi.org/10.1182/bloodadvances.2023011271
Published: 2023
Includes: Supplemental data
Journal Articles

Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma

Clinical Trials & Observations
Jia Ruan, Jasmine Zain, Brett Palmer, Borko Jovanovic, Xinlei Mi, Alok Swaroop, Jane N. Winter, Leo I. Gordon, Reem Karmali, Jonathan Moreira, Adam M. Petrich, Barbara Pro
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5771–5779.
https://doi.org/10.1182/bloodadvances.2023009767
Published: 2023
Includes: Supplemental data
Journal Articles

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma

Clinical Trials & Observations
Pamela B. Allen, Xinyan Lu, Qing Chen, Kaitlyn O’Shea, Joan S. Chmiel, Liron Barnea Slonim, Madina Sukhanova, Hatice Savas, Andrew M. Evens, Ranjana Advani, Barbara Pro, Reem Karmali, Brett Palmer, Robert A. Bayer, Robert M. Eisner, Eric Mou, Gary Dillehay, Leo I. Gordon, Jane N. Winter
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2670–2676.
https://doi.org/10.1182/bloodadvances.2022008116
Published: 2023
Journal Articles

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

Yong Li, Zijun Y. Xu-Monette, Jeremy Abramson, Aliyah R. Sohani, Govind Bhagat, Alexandar Tzankov, Carlo Visco, Shanxiang Zhang, Karen Dybkaer, Zenggang Pan, Min Xu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Heounjeong Go, J. Han van Krieken, Jane N. Winter, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Miguel A. Piris, Yingjun Wang, Mingzhi Zhang, Ken H. Young
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1308–1311.
https://doi.org/10.1182/bloodadvances.2022008550
Published: 2023
Includes: Supplemental data
Journal Articles

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

Zijun Y. Xu-Monette, Hongwei Zhang, Feng Zhu, Alexandar Tzankov, Govind Bhagat, Carlo Visco, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Hua You, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Fredrick B. Hagemeister, Babak Shahbaba, Ivan De Dios, Hong Zhang, Yong Li, Bing Xu, Maher Albitar, Ken H. Young
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3391–3404.
https://doi.org/10.1182/bloodadvances.2020001949
Published: 2020
Includes: Supplemental data